Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N versus Custodiol for organ preservation in liver transplantation
2019-001872-12Phase 3Active
- Sponsor
- Franz Köhler Chemie
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in hepatic disease comparing Custodiol-N with Custodiol (2 arms). Primary endpoint: Area under the curve of alanine aminotransferase during 7 days after transplantation. Started Sep 2021; status: active.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)HTK Custodiol
03
Conditions
hepatic disease
Beyond the preview
Go deeper on 2019-001872-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001872-12.